Literature DB >> 15056274

Genetic inactivation of prohormone convertase (PC1) causes a reduction in cholecystokinin (CCK) levels in the hippocampus, amygdala, pons and medulla in mouse brain that correlates with the degree of colocalization of PC1 and CCK mRNA in these structures in rat brain.

B M Cain1, K Connolly, A C Blum, D Vishnuvardhan, J E Marchand, X Zhu, D F Steiner, M C Beinfeld.   

Abstract

Prohormone convertase (PC1) is found in endocrine cell lines that express cholecystokinin (CCK) mRNA and process pro CCK to biologically active products. Other studies have demonstrated that PC1 may be a one of the enzymes responsible for the endoproteolytic cleavages that occur in pro CCK during its biosynthesis and processing. Prohormone convertase 1 (PC1) has a distribution that is similar to cholecystokinin (CCK) in rat brain. A moderate to high percentage of CCK mRNA-positive neurons express PC1 mRNA. CCK levels were measured in PC1 knockout and control mice to assess the degree to which loss of PC1 changed CCK content. CCK levels were decreased 62% in hippocampus, 53% in amygdala and 57% in pons-medulla in PC1 knockout mice as compared to controls. These results are highly correlated with the colocalization of CCK and PC1. The majority of CCK mRNA-positive neurons in the pyramidal cell layer of the hippocampus express PC1 mRNA and greater than 50% of CCK mRNA-positive neurons in several nuclei of the amygdala also express PC1. These results demonstrate that PC1 is important for CCK processing. PC2 and PC5 are also widely colocalized with CCK. It may be that PC2, PC5 or another non-PC enzyme are able to substitute for PC1 and sustain production of some amidated CCK. Together these enzymes may represent a redundant system to insure the production of CCK.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056274     DOI: 10.1046/j.1471-4159.2003.02295.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

Review 1.  Protease pathways in peptide neurotransmission and neurodegenerative diseases.

Authors:  Vivian Y H Hook
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

Review 2.  Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides.

Authors:  Lydiane Funkelstein; Margery Beinfeld; Ardalan Minokadeh; James Zadina; Vivian Hook
Journal:  Neuropeptides       Date:  2010-11-02       Impact factor: 3.286

Review 3.  Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease.

Authors:  Vivian Hook; Lydiane Funkelstein; Jill Wegrzyn; Steven Bark; Mark Kindy; Gregory Hook
Journal:  Biochim Biophys Acta       Date:  2011-09-08

4.  The cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1/3, 2, and 5/6.

Authors:  Jens F Rehfeld; Jens R Bundgaard; Jens Hannibal; Xiaorong Zhu; Christina Norrbom; Donald F Steiner; Lennart Friis-Hansen
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

5.  Cathepsin L plays a major role in cholecystokinin production in mouse brain cortex and in pituitary AtT-20 cells: protease gene knockout and inhibitor studies.

Authors:  Margery C Beinfeld; Lydiane Funkelstein; Thierry Foulon; Sandrine Cadel; Kouki Kitagawa; Thomas Toneff; Thomas Reinheckel; Christoph Peters; Vivian Hook
Journal:  Peptides       Date:  2009-07-07       Impact factor: 3.750

Review 6.  Mouse Models of Human Proprotein Convertase Insufficiency.

Authors:  Manita Shakya; Iris Lindberg
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.